Journal of Aging Research
Volume 2011 (2011), Article ID 963172, 15 pages
http://dx.doi.org/10.4061/2011/963172
Review Article
Regulation of Senescence in Cancer and Aging
Department of Cell Biology, University of Massachusetts Medical School, 55 Lake Avenue North, S7-125, Worcester, MA 01655, USA
Received 15 December 2010; Accepted 12 January 2011
Academic Editor: Amancio Carnero
Copyright © 2011 Yahui Kong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- L. Hayflick and P. S. Moorhead, “The serial cultivation of human diploid cell strains,” Experimental Cell Research, vol. 25, no. 3, pp. 585–621, 1961. View at Google Scholar · View at Scopus
- P. J. Vojta and J. C. Barrett, “Genetic analysis of cellular senescence,” Biochimica et Biophysica Acta, vol. 1242, no. 1, pp. 29–41, 1995. View at Publisher · View at Google Scholar · View at Scopus
- S. W. Sherwood, D. Rush, J. L. Ellsworth, and R. T. Schimke, “Defining cellular senescence in IMR-90 cells: a flow cytometric analysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 23, pp. 9086–9090, 1988. View at Google Scholar · View at Scopus
- V. J. Cristofalo, P. D. Phillips, T. Sorger, and G. Gerhard, “Alterations in the responsiveness of senescent cells to growth factors,” Journals of Gerontology, vol. 44, no. 6, pp. 55–62, 1989. View at Google Scholar · View at Scopus
- T. Matsumura, Z. Zerrudo, and L. Hayflick, “Senescent human diploid cells in culture: survival, DNA synthesis and morphology,” Journals of Gerontology, vol. 34, no. 3, pp. 328–334, 1979. View at Google Scholar · View at Scopus
- E. Wang, “Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved,” Cancer Research, vol. 55, no. 11, pp. 2284–2292, 1995. View at Google Scholar · View at Scopus
- B. Hampel, M. Wagner, D. Teis, W. Zwerschke, L. A. Huber, and P. Jansen-Dürr, “Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3,” Aging Cell, vol. 4, no. 6, pp. 325–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. Goldstein, “Replicative senescence: the human fibroblast comes of age,” Science, vol. 249, no. 4973, pp. 1129–1133, 1990. View at Google Scholar · View at Scopus
- G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
- V. J. Cristofalo, C. Volker, M. K. Francis, and M. Tresini, “Age-dependent modifications of gene expression in human fibroblasts,” Critical Reviews in Eukaryotic Gene Expression, vol. 8, no. 1, pp. 43–80, 1998. View at Google Scholar · View at Scopus
- D. N. Shelton, E. Chang, P. S. Whittier, D. Choi, and W. D. Funk, “Microarray analysis of replicative senescence,” Current Biology, vol. 9, no. 17, pp. 939–945, 1999. View at Publisher · View at Google Scholar · View at Scopus
- S. R. Schwarze, S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard, “Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells,” Journal of Biological Chemistry, vol. 277, no. 17, pp. 14877–14883, 2002. View at Publisher · View at Google Scholar · View at Scopus
- H. Zhang, K. H. Pan, and S. N. Cohen, “Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 6, pp. 3251–3256, 2003. View at Publisher · View at Google Scholar · View at Scopus
- H. Zhang, B. S. Herbert, K. H. Pan, J. W. Shay, and S. N. Cohen, “Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions,” Oncogene, vol. 23, no. 37, pp. 6193–6198, 2004. View at Publisher · View at Google Scholar · View at Scopus
- J. P. Coppe, K. Kauser, J. Campisi, and C. M. Beauséjour, “Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence,” Journal of Biological Chemistry, vol. 281, no. 40, pp. 29568–29574, 2006. View at Publisher · View at Google Scholar · View at Scopus
- J. P. Coppé, C. K. Patil, F. Rodier et al., “Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor,” PLoS Biology, vol. 6, no. 12, article e301, pp. 2853–2868, 2008. View at Publisher · View at Google Scholar · View at Scopus
- T. Kuilman and D. S. Peeper, “Senescence-messaging secretome: SMS-ing cellular stress,” Nature Reviews Cancer, vol. 9, no. 2, pp. 81–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
- M. Narita, S. Nũnez, E. Heard et al., “Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence,” Cell, vol. 113, no. 6, pp. 703–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
- R. Zhang, M. V. Poustovoitov, X. Ye et al., “Formation of macroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA,” Developmental Cell, vol. 8, no. 1, pp. 19–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
- M. Narita, M. Narita, V. Krizhanovsky et al., “A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation,” Cell, vol. 126, no. 3, pp. 503–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
- L. Hayflick, “The cell biology of human aging,” The New England Journal of Medicine, vol. 295, no. 23, pp. 1302–1308, 1976. View at Google Scholar · View at Scopus
- S. Goldstein and D. P. Singal, “Senescence of cultured human fibroblasts: mitotic versus metabolic time,” Experimental Cell Research, vol. 88, no. 2, pp. 359–364, 1974. View at Google Scholar · View at Scopus
- C. B. Harley, A. B. Futcher, and C. W. Greider, “Telomeres shorten during ageing of human fibroblasts,” Nature, vol. 345, no. 6274, pp. 458–460, 1990. View at Publisher · View at Google Scholar · View at Scopus
- C. B. Harley, “Telomere loss: mitotic clock or genetic time bomb?” Mutation Research, vol. 256, no. 2–6, pp. 271–282, 1991. View at Google Scholar · View at Scopus
- S. E. Holt, J. W. Shay, and W. E. Wright, “Refining the telomere-telomerase hypothesis of aging and cancer,” Nature Biotechnology, vol. 14, no. 7, pp. 836–839, 1996. View at Google Scholar · View at Scopus
- E. H. Blackburn, “Switching and signaling at the telomere,” Cell, vol. 106, no. 6, pp. 661–673, 2001. View at Publisher · View at Google Scholar · View at Scopus
- T. de Lange, L. Shiue, R. M. Myers et al., “Structure and variability of human chromosome ends,” Molecular and Cellular Biology, vol. 10, no. 2, pp. 518–527, 1990. View at Google Scholar · View at Scopus
- U. M. Martens, E. A. Chavez, S. S. S. Poon, C. Schmoor, and P. M. Lansdorp, “Accumulation of short telomeres in human fibroblasts prior to replicative senescence,” Experimental Cell Research, vol. 256, no. 1, pp. 291–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
- C. W. Greider and E. H. Blackburn, “Identification of a specific telomere terminal transferase activity in tetrahymena extracts,” Cell, vol. 43, no. 2 I, pp. 405–413, 1985. View at Google Scholar · View at Scopus
- N. W. Kim, M. A. Piatyszek, K. R. Prowse et al., “Specific association of human telomerase activity with immortal cells and cancer,” Science, vol. 266, no. 5193, pp. 2011–2015, 1994. View at Google Scholar · View at Scopus
- J. W. Shay and S. Bacchetti, “A survey of telomerase activity in human cancer,” European Journal of Cancer Part A, vol. 33, no. 5, pp. 787–791, 1997. View at Publisher · View at Google Scholar · View at Scopus
- H. Vaziri and S. Benchimol, “Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span,” Current Biology, vol. 8, no. 5, pp. 279–282, 1998. View at Google Scholar · View at Scopus
- T. Kiyono, S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz, “Both Rb/ inactivation and telomerase activity are required to immortalize human epithelial cells,” Nature, vol. 396, no. 6706, pp. 84–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
- A. G. Bodnar, M. Ouellette, M. Frolkis et al., “Extension of life-span by introduction of telomerase into normal human cells,” Science, vol. 279, no. 5349, pp. 349–352, 1998. View at Publisher · View at Google Scholar · View at Scopus
- W. C. Hahn, S. A. Stewart, M. W. Brooks et al., “Inhibition of telomerase limits the growth of human cancer cells,” Nature Medicine, vol. 5, no. 10, pp. 1164–1170, 1999. View at Publisher · View at Google Scholar · View at Scopus
- X. Zhang, V. Mar, W. Zhou, L. Harrington, and M. O. Robinson, “Telomere shortening and apoptosis in telomerase-inhibited human tumor cells,” Genes & Development, vol. 13, no. 18, pp. 2388–2399, 1999. View at Publisher · View at Google Scholar · View at Scopus
- F. d'Adda di Fagagna, P. M. Reaper, L. Clay-Farrace et al., “A DNA damage checkpoint response in telomere-initiated senescence,” Nature, vol. 426, no. 6963, pp. 194–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
- U. Herbig, W. A. Jobling, B. P. C. Chen, D. J. Chen, and J. M. Sedivy, “Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21, but not p16,” Molecular Cell, vol. 14, no. 4, pp. 501–513, 2004. View at Publisher · View at Google Scholar · View at Scopus
- H. Takai, A. Smogorzewska, and T. de Lange, “DNA damage foci at dysfunctional telomeres,” Current Biology, vol. 13, no. 17, pp. 1549–1556, 2003. View at Publisher · View at Google Scholar · View at Scopus
- M. Serrano, A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe, “Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and ,” Cell, vol. 88, no. 5, pp. 593–602, 1997. View at Publisher · View at Google Scholar · View at Scopus
- J. Zhu, D. Woods, M. McMahon, and J. M. Bishop, “Senescence of human fibroblasts induced by oncogenic Raf,” Genes & Development, vol. 12, no. 19, pp. 2997–3007, 1998. View at Google Scholar · View at Scopus
- A. W. Lin, M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe, “Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling,” Genes & Development, vol. 12, no. 19, pp. 3008–3019, 1998. View at Google Scholar · View at Scopus
- V. V. Ogryzko, T. H. Hirai, V. R. Russanova, D. A. Barbie, and B. H. Howard, “Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 5210–5218, 1996. View at Google Scholar · View at Scopus
- B. Villeponteau, “The heterochromatin loss model of aging,” Experimental Gerontology, vol. 32, no. 4-5, pp. 383–394, 1997. View at Publisher · View at Google Scholar · View at Scopus
- B. H. Howard, “Replicative senescence: considerations relating to the stability of heterochromatin domains,” Experimental Gerontology, vol. 31, no. 1-2, pp. 281–293, 1996. View at Publisher · View at Google Scholar · View at Scopus
- Q. Chen, A. Fischer, J. D. Reagan, L. J. Yan, and B. N. Ames, “Oxidative DNA damage and senescence of human diploid fibroblast cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4337–4341, 1995. View at Google Scholar · View at Scopus
- T. von Zglinicki, G. Saretzki, W. Docke, and C. Lotze, “Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?” Experimental Cell Research, vol. 220, no. 1, pp. 186–193, 1995. View at Publisher · View at Google Scholar · View at Scopus
- S. Parrinello, E. Samper, A. Krtolica, J. Goldstein, S. Melov, and J. Campisi, “Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts,” Nature Cell Biology, vol. 5, no. 8, pp. 741–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. J. Robles and G. R. Adami, “Agents that cause DNA double strand breaks lead to enrichment and the premature senescence of normal fibroblasts,” Oncogene, vol. 16, no. 9, pp. 1113–1123, 1998. View at Google Scholar · View at Scopus
- A. Di Leonardo, S. P. Linke, K. Clarkin, and G. M. Wahl, “DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts,” Genes & Development, vol. 8, no. 21, pp. 2540–2551, 1994. View at Google Scholar · View at Scopus
- R. D. Ramirez, C. P. Morales, B. S. Herbert et al., “Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions,” Genes & Development, vol. 15, no. 4, pp. 398–403, 2001. View at Publisher · View at Google Scholar · View at Scopus
- C. J. Sherr and R. A. DePinho, “Cellular senescence: mitotic clock or culture shock?” Cell, vol. 102, no. 4, pp. 407–410, 2000. View at Google Scholar · View at Scopus
- N. R. Forsyth, A. P. Evans, J. W. Shay, and W. E. Wright, “Developmental differences in the immortalization of lung fibroblasts by telomerase,” Aging Cell, vol. 2, no. 5, pp. 235–243, 2003. View at Google Scholar
- T. von Zglinicki, R. Pilger, and N. Sitte, “Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts,” Free Radical Biology and Medicine, vol. 28, no. 1, pp. 64–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
- W. E. Wright and J. W. Shay, “Cellular senescence as a tumor-protection mechanism: the essential role of counting,” Current Opinion in Genetics and Development, vol. 11, no. 1, pp. 98–103, 2001. View at Publisher · View at Google Scholar · View at Scopus
- W. E. Wright and J. W. Shay, “Historical claims and current interpretations of replicative aging,” Nature Biotechnology, vol. 20, no. 7, pp. 682–688, 2002. View at Publisher · View at Google Scholar · View at Scopus
- S. Wei, W. Wei, and J. M. Sedivy, “Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts,” Cancer Research, vol. 59, no. 7, pp. 1539–1543, 1999. View at Google Scholar · View at Scopus
- M. Serrano and M. A. Blasco, “Putting the stress on senescence,” Current Opinion in Cell Biology, vol. 13, no. 6, pp. 748–753, 2001. View at Publisher · View at Google Scholar · View at Scopus
- N. E. Sharpless and R. A. DePinho, “Telomeres, stem cells, senescence, and cancer,” Journal of Clinical Investigation, vol. 113, no. 2, pp. 160–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
- J. Pedro de Magalhães, F. Chainiaux, F. de Longueville et al., “Gene expression and regulation in H2O2-induced premature senescence of human foreskin fibroblasts expressing or not telomerase,” Experimental Gerontology, vol. 39, no. 9, pp. 1379–1389, 2004. View at Publisher · View at Google Scholar · View at Scopus
- M. Collado, J. Gil, A. Efeyan et al., “Tumour biology: senescence in premalignant tumours,” Nature, vol. 436, no. 7051, p. 642, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. Franco, A. Canela, P. Klatt, and M. A. Blasco, “Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models,” Carcinogenesis, vol. 26, no. 9, pp. 1613–1626, 2005. View at Publisher · View at Google Scholar · View at Scopus
- B. W. Darbro, G. B. Schneider, and A. J. Klingelhutz, “Co-regulation of p16 and migratory genes in culture conditions that lead to premature senescence in human keratinocytes,” Journal of Investigative Dermatology, vol. 125, no. 3, pp. 499–509, 2005. View at Publisher · View at Google Scholar · View at Scopus
- I. Ben-Porath and R. A. Weinberg, “The signals and pathways activating cellular senescence,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 5, pp. 961–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
- N. E. Sharpless and R. A. DePinho, “Cancer: crime and punishment,” Nature, vol. 436, no. 7051, pp. 636–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
- E. Hara, H. Tsurui, A. Shinozaki, S. Nakada, and K. Oda, “Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1,” Biochemical and Biophysical Research Communications, vol. 179, no. 1, pp. 528–534, 1991. View at Google Scholar · View at Scopus
- J. W. Shay, O. M. Pereira-Smith, and W. E. Wright, “A role for both RB and p53 in the regulation of human cellular senescence,” Experimental Cell Research, vol. 196, no. 1, pp. 33–39, 1991. View at Publisher · View at Google Scholar · View at Scopus
- W. Wei, U. Herbig, S. Wei, A. Dutriaux, and J. M. Sedivy, “Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts,” EMBO Reports, vol. 4, no. 11, pp. 1061–1066, 2003. View at Publisher · View at Google Scholar · View at Scopus
- A. Smogorzewska and T. de Lange, “Different telomere damage signaling pathways in human and mouse cells,” The EMBO Journal, vol. 21, no. 16, pp. 4338–4348, 2002. View at Publisher · View at Google Scholar · View at Scopus
- J. Campisi and F. d'Adda Di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
- C. A. Afshari, P. J. Vojta, L. A. Annab, P. A. Futreal, T. B. Willard, and J. C. Barrett, “Investigation of the role of G1/S cell cycle mediators in cellular senescence,” Experimental Cell Research, vol. 209, no. 2, pp. 231–237, 1993. View at Publisher · View at Google Scholar · View at Scopus
- P. Atadja, H. Wong, I. Garkavtsev, C. Veillette, and K. Riabowol, “Increased activity of p53 in senescing fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 18, pp. 8348–8352, 1995. View at Publisher · View at Google Scholar · View at Scopus
- K. Webley, J. A. Bond, C. J. Jones et al., “Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage,” Molecular and Cellular Biology, vol. 20, no. 8, pp. 2803–2808, 2000. View at Publisher · View at Google Scholar · View at Scopus
- J. Bond, M. Haughton, J. Blaydes, V. Gire, D. Wynford-Thomas, and F. Wyllie, “Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence,” Oncogene, vol. 13, no. 10, pp. 2097–2104, 1996. View at Google Scholar · View at Scopus
- V. Gire, P. Roux, D. Wynford-Thomas, J. M. Brondello, and V. Dulic, “DNA damage checkpoint kinase Chk2 triggers replicative senescence,” The EMBO Journal, vol. 23, no. 13, pp. 2554–2563, 2004. View at Publisher · View at Google Scholar · View at Scopus
- V. Gire, “Dysfunctional telomeres at senescence signal cell cycle arrest via Chk2,” Cell Cycle, vol. 3, no. 10, pp. 1217–1220, 2004. View at Google Scholar · View at Scopus
- Q. M. Chen, J. C. Bartholomew, J. Campisi, M. Acosta, J. D. Reagan, and B. N. Ames, “Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication,” The Biochemical Journal, vol. 332, pp. 1–50, 1998. View at Google Scholar · View at Scopus
- G. Ferbeyre, E. de Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe, “PML is induced by oncogenic ras and promotes premature senescence,” Genes & Development, vol. 14, no. 16, pp. 2015–2027, 2000. View at Google Scholar · View at Scopus
- M. Pearson, R. Carbone, C. Sebastiani et al., “PML regulates p53 acetylation and premature senescence induced by oncogenic Ras,” Nature, vol. 406, no. 6792, pp. 207–210, 2000. View at Publisher · View at Google Scholar
- F. J. Stott, S. Bates, M. C. James et al., “The alternative product from the human CDKN2A locus, , participates in a regulatory feedback loop with p53 and MDM2,” The EMBO Journal, vol. 17, no. 17, pp. 5001–5014, 1998. View at Publisher · View at Google Scholar · View at Scopus
- A. M. G. Dirac and R. Bernards, “Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53,” Journal of Biological Chemistry, vol. 278, no. 14, pp. 11731–11734, 2003. View at Publisher · View at Google Scholar · View at Scopus
- M. Harvey, A. T. Sands, R. S. Weiss et al., “In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice,” Oncogene, vol. 8, no. 9, pp. 2457–2467, 1993. View at Google Scholar · View at Scopus
- T. Kamijo, F. Zindy, M. F. Roussel et al., “Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product ,” Cell, vol. 91, no. 5, pp. 649–659, 1997. View at Google Scholar · View at Scopus
- C. J. Sherr and J. M. Roberts, “CDK inhibitors: positive and negative regulators of G-phase progression,” Genes & Development, vol. 13, no. 12, pp. 1501–1512, 1999. View at Google Scholar · View at Scopus
- V. Dulic, L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein, “Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11034–11038, 1993. View at Publisher · View at Google Scholar · View at Scopus
- A. Noda, Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith, “Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen,” Experimental Cell Research, vol. 211, no. 1, pp. 90–98, 1994. View at Publisher · View at Google Scholar · View at Scopus
- H. Tahara, K. Kamada, E. Sato et al., “Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan,” Oncogene, vol. 11, no. 6, pp. 1125–1132, 1995. View at Google Scholar · View at Scopus
- G. H. Stein, L. F. Drullinger, A. Soulard, and V. Dulić, “Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts,” Molecular and Cellular Biology, vol. 19, no. 3, pp. 2109–2117, 1999. View at Google Scholar · View at Scopus
- U. Herbig, W. Wei, A. Dutriaux, W. A. Jobling, and J. M. Sedivy, “Real-time imaging of transcriptional activation in live cells reveals rapid up-regulation of the cyclin-dependent kinase inhibitor gene CDKN1A in replicative cellular senescence,” Aging cell, vol. 2, no. 6, pp. 295–304, 2003. View at Google Scholar · View at Scopus
- M. Modestou, V. Puig-Antich, C. Korgaonkar, A. Eapen, and D. E. Quelle, “The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways,” Cancer Research, vol. 61, no. 7, pp. 3145–3150, 2001. View at Google Scholar · View at Scopus
- W. Wei, R. M. Hemmer, and J. M. Sedivy, “Role of p14 in replicative and induced senescence of human fibroblasts,” Molecular and Cellular Biology, vol. 21, no. 20, pp. 6748–6757, 2001. View at Publisher · View at Google Scholar · View at Scopus
- B. B. McConnell, M. Starborg, S. Brookes, and G. Peters, “Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts,” Current Biology, vol. 8, no. 6, pp. 351–354, 1998. View at Google Scholar · View at Scopus
- B. D. Chang, K. Watanabe, E. V. Broude et al., “Effects of p21 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 8, pp. 4291–4296, 2000. View at Google Scholar · View at Scopus
- J. P. Brown, W. Wei, and J. M. Sedivy, “Bypass of senescenoe after disruption of gene in normal diploid human fibroblasts,” Science, vol. 277, no. 5327, pp. 831–834, 1997. View at Publisher · View at Google Scholar · View at Scopus
- A. S. C. Medcalf, A. J. P. Klein-Szanto, and V. J. Cristofalo, “Expression of p21 is not required for senescence of human fibroblasts,” Cancer Research, vol. 56, no. 20, pp. 4582–4585, 1996. View at Google Scholar · View at Scopus
- C. M. Beauséjour, A. Krtolica, F. Galimi et al., “Reversal of human cellular senescence: roles of the p53 and p16 pathways,” The EMBO Journal, vol. 22, no. 16, pp. 4212–4222, 2003. View at Publisher · View at Google Scholar · View at Scopus
- D. A. Alcorta, Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett, “Involvement of the cyclin-dependent kinase inhibitor in replicative senescence of normal human fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 13742–13747, 1996. View at Publisher · View at Google Scholar · View at Scopus
- E. Hara, R. Smith, D. Parry, H. Tahara, S. Stone, and G. Peters, “Regulation of p16 expression and its implications for cell immortalization and senescence,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 859–867, 1996. View at Google Scholar · View at Scopus
- H. Wong and K. Riabowol, “Differential CDK-inhibitor gene expression in aging human diploid fibroblasts,” Experimental Gerontology, vol. 31, no. 1-2, pp. 311–325, 1996. View at Publisher · View at Google Scholar · View at Scopus
- K. Itahana, Y. Zou, Y. Itahana et al., “Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1,” Molecular and Cellular Biology, vol. 23, no. 1, pp. 389–401, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. R. Romanov, B. K. Kozakiewicz, C. R. Holst, M. R. Stampfer, L. M. Haupt, and T. D. Tlsty, “Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes,” Nature, vol. 409, no. 6820, pp. 633–637, 2001. View at Publisher · View at Google Scholar
- W. Y. Kim and N. E. Sharpless, “The regulation of INK4/ARF in cancer and aging,” Cell, vol. 127, no. 2, pp. 265–275, 2006. View at Publisher · View at Google Scholar · View at Scopus
- J. Gil and G. Peters, “Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all,” Nature Reviews Molecular Cell Biology, vol. 7, no. 9, pp. 667–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
- C. J. Collins and J. M. Sedivy, “Involvement of the INK4a/Arf gene locus in senescence,” Aging Cell, vol. 2, no. 3, pp. 145–150, 2003. View at Google Scholar · View at Scopus
- J. L. Jacobs, K. Kieboom, S. Marino, R. A. DePinho, and M. van Lohuizen, “The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus,” Nature, vol. 397, no. 6715, pp. 164–168, 1999. View at Publisher · View at Google Scholar · View at Scopus
- A. P. Bracken, D. Kleine-Kohlbrecher, N. Dietrich et al., “The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells,” Genes & Development, vol. 21, no. 5, pp. 525–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Gil, D. Bernard, D. Martínez, and D. Beach, “Polycomb CBX7 has a unifying role in cellular lifespan,” Nature Cell Biology, vol. 6, no. 1, pp. 67–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
- N. Dietrich, A. P. Bracken, E. Trinh et al., “Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus,” The EMBO Journal, vol. 26, no. 6, pp. 1637–1648, 2007. View at Publisher · View at Google Scholar
- E. Hara, T. Yamaguchi, H. Nojima et al., “Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts,” Journal of Biological Chemistry, vol. 269, no. 3, pp. 2139–2145, 1994. View at Google Scholar · View at Scopus
- W. Zheng, H. Wang, L. Xue, Z. Zhang, and T. Tong, “Regulation of cellular senescence and p16 expression by Id1 and E47 proteins in human diploid fibroblast,” Journal of Biological Chemistry, vol. 279, no. 30, pp. 31524–31532, 2004. View at Publisher · View at Google Scholar · View at Scopus
- N. Ohtani, Z. Zebedee, T. J. G. Huot et al., “Opposing effects of Ets and Id proteins on p16 expression during cellular senescence,” Nature, vol. 409, no. 6823, pp. 1067–1070, 2001. View at Publisher · View at Google Scholar · View at Scopus
- R. M. Alani, A. Z. Young, and C. B. Shifflett, “Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 7812–7816, 2001. View at Publisher · View at Google Scholar · View at Scopus
- R. M. Alani, J. Hasskarl, M. Grace, M. C. Hernandez, M. A. Israel, and K. Münger, “Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9637–9641, 1999. View at Publisher · View at Google Scholar · View at Scopus
- B. J. Nickoloff, V. Chaturvedi, P. Bacon, J. Z. Qin, M. F. Denning, and M. O. Diaz, “Id-1 delays senescence but does not immortalize keratinocytes,” Journal of Biological Chemistry, vol. 275, no. 36, pp. 27501–27504, 2000. View at Publisher · View at Google Scholar · View at Scopus
- J. Tang, G. M. Gordon, B. J. Nickoloff, and K. E. Foreman, “The helix-loop-helix protein Id-1 delays onset of replicative senescence in human endothelial cells,” Laboratory Investigation, vol. 82, no. 8, pp. 1073–1079, 2002. View at Google Scholar · View at Scopus
- N. E. Sharpless, N. Bardeesy, K. H. Lee et al., “Loss of p16 with retention of p19 predisposes mice to tumorigenesis,” Nature, vol. 413, no. 6851, pp. 86–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
- B. Vogelstein and K. W. Kinzler, “The multistep nature of cancer,” Trends in Genetics, vol. 9, no. 4, pp. 138–141, 1993. View at Publisher · View at Google Scholar · View at Scopus
- J. Campisi, “Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors,” Cell, vol. 120, no. 4, pp. 513–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
- R. Sager, “Senescence as a mode of tumor suppression,” Environmental Health Perspectives, vol. 93, pp. 59–62, 1991. View at Google Scholar · View at Scopus
- D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
- T. M. Bryan, A. Englezou, J. Gupta, S. Bacchetti, and R. R. Reddel, “Telomere elongation in immortal human cells without detectable telomerase activity,” The EMBO Journal, vol. 14, no. 17, pp. 4240–4248, 1995. View at Google Scholar · View at Scopus
- A. Muntoni and R. R. Reddel, “The first molecular details of ALT in human tumor cells,” Human Molecular Genetics, vol. 14, no. 2, pp. R191–R196, 2005. View at Publisher · View at Google Scholar · View at Scopus
- W. C. Hahn, C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg, “Creation of human tumour cells with defined genetic elements,” Nature, vol. 400, no. 6743, pp. 464–468, 1999. View at Publisher · View at Google Scholar · View at Scopus
- E. González-Suárez, E. Samper, A. Ramírez et al., “Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes,” The EMBO Journal, vol. 20, no. 11, pp. 2619–2630, 2001. View at Publisher · View at Google Scholar · View at Scopus
- S. E. Artandi, S. Alson, M. K. Tietze et al., “Constitutive telomerase expression promotes mammary carcinomas in aging mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8191–8196, 2002. View at Publisher · View at Google Scholar · View at Scopus
- A. Canela, J. Martín-Caballero, J. M. Flores, and M. A. Blasco, “Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-tert mice,” Molecular and Cellular Biology, vol. 24, no. 10, pp. 4275–4293, 2004. View at Publisher · View at Google Scholar · View at Scopus
- A. K. Bednarek, Y. Chu, T. J. Slaga, and C. M. Aldaz, “Telomerase and cell proliferation in mouse skin papillomas,” Molecular Carcinogenesis, vol. 20, no. 4, pp. 329–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
- E. González-Suárez, J. M. Flores, and M. A. Blasco, “Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development,” Molecular and Cellular Biology, vol. 22, no. 20, pp. 7291–7301, 2002. View at Publisher · View at Google Scholar
- M. A. Blasco, H. W. Lee, M. P. Hande et al., “Telomere shortening and tumor formation by mouse cells lacking telomerase RNA,” Cell, vol. 91, no. 1, pp. 25–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
- C. M. Khoo, D. R. Carrasco, M. W. Bosenberg, J. H. Paik, and R. A. DePinho, “Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 10, pp. 3931–3936, 2007. View at Publisher · View at Google Scholar · View at Scopus
- R. A. Greenberg, L. Chin, A. Femino et al., “Short dysfunctional telomeres impair tumorigenesis in the cancer-prone mouse,” Cell, vol. 97, no. 4, pp. 515–525, 1999. View at Publisher · View at Google Scholar · View at Scopus
- E. González-Suárez, E. Samper, J. M. Flores, and M. A. Blasco, “Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis,” Nature Genetics, vol. 26, no. 1, pp. 114–117, 2000. View at Publisher · View at Google Scholar · View at Scopus
- K. L. Rudolph, M. Millard, M. W. Bosenberg, and R. A. DePinho, “Telomere dysfunction and evolution of intestinal carcinoma in mice and humans,” Nature Genetics, vol. 28, no. 2, pp. 155–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
- K. K. Wong, R. S. Maser, R. M. Bachoo et al., “Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing,” Nature, vol. 421, no. 6923, pp. 643–648, 2003. View at Publisher · View at Google Scholar · View at Scopus
- L. Qi, M. A. Strong, B. O. Karim, D. L. Huso, and C. W. Greider, “Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation,” Nature Cell Biology, vol. 7, no. 7, pp. 706–711, 2005. View at Publisher · View at Google Scholar · View at Scopus
- L. Qi, M. A. Strong, B. O. Karim, M. Armanios, D. L. Huso, and C. W. Greider, “Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis,” Cancer Research, vol. 63, no. 23, pp. 8188–8196, 2003. View at Google Scholar · View at Scopus
- X. Guo, Y. Deng, Y. Lin et al., “Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis,” The EMBO Journal, vol. 26, no. 22, pp. 4709–4719, 2007. View at Publisher · View at Google Scholar · View at Scopus
- A. Lechel, H. Holstege, Y. Begus et al., “Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease,” Gastroenterology, vol. 132, no. 4, pp. 1465–1475, 2007. View at Publisher · View at Google Scholar · View at Scopus
- E. González-Suárez, F. A. Goytisolo, J. M. Flores, and M. A. Blasco, “Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea,” Cancer Research, vol. 63, no. 21, pp. 7047–7050, 2003. View at Google Scholar · View at Scopus
- K. L. Rudolph, S. Chang, H. W. Lee et al., “Longevity, stress response, and cancer in aging telomerase-deficient mice,” Cell, vol. 96, no. 5, pp. 701–712, 1999. View at Google Scholar · View at Scopus
- P. A. Farazi, J. Glickman, J. Horner, and R. A. DePinho, “Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression,” Cancer Research, vol. 66, no. 9, pp. 4766–4773, 2006. View at Publisher · View at Google Scholar · View at Scopus
- D. M. Feldser and C. W. Greider, “Short telomeres limit tumor progression in vivo by inducing senescence,” Cancer Cell, vol. 11, no. 5, pp. 461–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
- W. Cosme-Blanco, M. F. Shen, A. J. F. Lazar et al., “Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence,” EMBO Reports, vol. 8, no. 5, pp. 497–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Braig, S. Lee, C. Loddenkemper et al., “Oncogene-induced senescence as an initial barrier in lymphoma development,” Nature, vol. 436, no. 7051, pp. 660–665, 2005. View at Publisher · View at Google Scholar · View at Scopus
- C. J. Sarkisian, B. A. Keister, D. B. Stairs, R. B. Boxer, S. E. Moody, and L. A. Chodosh, “Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis,” Nature Cell Biology, vol. 9, no. 5, pp. 493–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. P. Morton, P. Timpson, S. A. Karim et al., “Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 246–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
- E. L. Denchi, C. Attwooll, D. Pasini, and K. Helin, “Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland,” Molecular and Cellular Biology, vol. 25, no. 7, pp. 2660–2672, 2005. View at Publisher · View at Google Scholar · View at Scopus
- Z. Chen, L. C. Trotman, D. Shaffer et al., “Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis,” Nature, vol. 436, no. 7051, pp. 725–730, 2005. View at Publisher · View at Google Scholar · View at Scopus
- D. Dankort, E. Filenova, M. Collado, M. Serrano, K. Jones, and M. McMahon, “A new mouse model to explore the initiation, progression, and therapy of BRAF-induced lung tumors,” Genes & Development, vol. 21, no. 4, pp. 379–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
- L. Ha, T. Lchikawa, M. Anver et al., “ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 10968–10973, 2007. View at Publisher · View at Google Scholar
- N. Dhomen, J. S. Reis-Filho, S. da Rocha Dias et al., “Oncogenic Braf induces melanocyte senescence and melanoma in mice,” Cancer Cell, vol. 15, no. 4, pp. 294–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
- V. K. Goel, N. Ibrahim, G. Jiang et al., “Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice,” Oncogene, vol. 28, no. 23, pp. 2289–2298, 2009. View at Publisher · View at Google Scholar · View at Scopus
- P. K. Majumder, C. Grisanzio, F. O'Connell et al., “A prostatic intraepithelial neoplasia-dependent p27 checkpoint induces senescence and inhibits cell proliferation and cancer progression,” Cancer Cell, vol. 14, no. 2, pp. 146–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. Xu, Q. Yu, R. Subrahmanyam, M. J. Difilippantonio, T. Ried, and J. M. Sen, “β-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo,” Molecular and Cellular Biology, vol. 28, no. 5, pp. 1713–1723, 2008. View at Publisher · View at Google Scholar · View at Scopus
- A. P. Young, S. Schisio, Y. A. Minamishima et al., “VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400,” Nature Cell Biology, vol. 10, no. 3, pp. 361–369, 2008. View at Publisher · View at Google Scholar · View at Scopus
- C. Michaloglou, L. C. W. Vredeveld, M. S. Soengas et al., “BRAF-associated senescence-like cell cycle arrest of human naevi,” Nature, vol. 436, no. 7051, pp. 720–724, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. Courtois-Cox, S. M. Genther Williams, E. E. Reczek et al., “A negative feedback signaling network underlies oncogene-induced senescence,” Cancer Cell, vol. 10, no. 6, pp. 459–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
- V. C. Gray-Schopfer, S. C. Cheong, H. Chong et al., “Cellular senescence in naevi and immortalisation in melanoma: a role for p16?” British Journal of Cancer, vol. 95, no. 4, pp. 496–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
- J. Bartkova, N. Rezaei, M. Liontos et al., “Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints,” Nature, vol. 444, no. 7119, pp. 633–637, 2006. View at Publisher · View at Google Scholar · View at Scopus
- P. Sun, N. Yoshizuka, L. New et al., “PRAK is essential for ras-induced senescence and tumor suppression,” Cell, vol. 128, no. 2, pp. 295–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
- C. A. Schmitt, “Senescence, apoptosis and therapy—cutting the lifelines of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 286–295, 2003. View at Google Scholar · View at Scopus
- J. W. Shay and I. B. Roninson, “Hallmarks of senescence in carcinogenesis and cancer therapy,” Oncogene, vol. 23, no. 16, pp. 2919–2933, 2004. View at Publisher · View at Google Scholar · View at Scopus
- C. A. Schmitt, J. S. Fridman, M. Yang et al., “A senescence program controlled by p53 and p16 contributes to the outcome of cancer therapy,” Cell, vol. 109, no. 3, pp. 335–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
- W. E. Wright, M. A. Piatyszek, W. E. Rainey, W. Byrd, and J. W. Shay, “Telomerase activity in human germline and embryonic tissues and cells,” Developmental Genetics, vol. 18, no. 2, pp. 173–179, 1996. View at Publisher · View at Google Scholar · View at Scopus
- G. A. Ulaner, J. F. Hu, T. H. Vu, L. C. Giudice, and A. R. Hoffman, “Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts,” Cancer Research, vol. 58, no. 18, pp. 4168–4172, 1998. View at Google Scholar · View at Scopus
- C. B. Harley, “Telomerase and cancer therapeutics,” Nature Reviews Cancer, vol. 8, no. 3, pp. 167–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
- L. R. Kelland, “Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics—current status and future prospects,” European Journal of Cancer, vol. 41, no. 7, pp. 971–979, 2005. View at Publisher · View at Google Scholar · View at Scopus
- J. W. Shay and W. E. Wright, “Telomerase therapeutics for cancer: challenges and new directions,” Nature Reviews Drug Discovery, vol. 5, no. 7, pp. 577–584, 2006. View at Publisher · View at Google Scholar · View at Scopus
- K. Damm, U. Hemmann, P. Garin-Chesa et al., “A highly selective telomerase inhibitor limiting human cancer cell proliferation,” The EMBO Journal, vol. 20, no. 24, pp. 6958–6968, 2002. View at Publisher · View at Google Scholar
- J. H. Kim, J. H. Kim, G. E. Lee, S. W. Kim, and I. K. Chung, “Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells,” The Biochemical Journal, vol. 373, no. 2, pp. 523–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
- A. Preto, S. K. Singhrao, M. F. Haughton, D. Kipling, D. Wynford-Thomas, and C. J. Jones, “Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy,” Oncogene, vol. 23, no. 23, pp. 4136–4145, 2004. View at Publisher · View at Google Scholar · View at Scopus
- J. F. Riou, L. Guittat, P. Mailliet et al., “Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2672–2677, 2002. View at Publisher · View at Google Scholar · View at Scopus
- M. A. Shammas, H. Koley, D. G. Beer, C. Li, R. K. Goyal, and N. C. Munshi, “Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor,” Gastroenterology, vol. 126, no. 5, pp. 1337–1346, 2004. View at Publisher · View at Google Scholar · View at Scopus
- M. W. Djojosubroto, A. C. Chin, N. Go et al., “Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma,” Hepatology, vol. 42, no. 5, pp. 1127–1136, 2005. View at Publisher · View at Google Scholar · View at Scopus
- P. F. Brunsvig, S. Aamdal, M. K. Gjertsen et al., “Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer,” Cancer Immunology, Immunotherapy, vol. 55, no. 12, pp. 1553–1564, 2006. View at Publisher · View at Google Scholar · View at Scopus
- W. G. Deng, G. Jayachandran, G. Wu, K. Xu, J. A. Roth, and L. Ji, “Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2β in human lung cancer cells,” Journal of Biological Chemistry, vol. 282, no. 36, pp. 26460–26470, 2007. View at Publisher · View at Google Scholar · View at Scopus
- A. E. Hochreiter, H. Xiao, E. M. Goldblatt et al., “Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer,” Clinical Cancer Research, vol. 12, no. 10, pp. 3184–3192, 2006. View at Publisher · View at Google Scholar · View at Scopus
- W. G. An, R. C. Schnur, L. Neckers, and M. V. Blagosklonny, “Depletion of , Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity,” Cancer Chemotherapy and Pharmacology, vol. 40, no. 1, pp. 60–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
- G. Dasgupta and J. Momand, “Geldanamycin prevents nuclear translocation of mutant p53,” Experimental Cell Research, vol. 237, no. 1, pp. 29–37, 1997. View at Publisher · View at Google Scholar · View at Scopus
- G. Selivanova, L. Ryabchenko, E. Jansson, V. Iotsova, and K. G. Wiman, “Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain,” Molecular and Cellular Biology, vol. 19, no. 5, pp. 3395–3402, 1999. View at Google Scholar · View at Scopus
- B. A. Foster, H. A. Coffey, M. J. Morin, and F. Rastinejad, “Pharmacological rescue of mutant p53 conformation and function,” Science, vol. 286, no. 5449, pp. 2507–2510, 1999. View at Publisher · View at Google Scholar · View at Scopus
- R. E. Buller, I. B. Runnebaum, B. Y. Karlan et al., “A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer,” Cancer Gene Therapy, vol. 9, no. 7, pp. 553–566, 2002. View at Publisher · View at Google Scholar · View at Scopus
- K. Butz, C. Denk, A. Ullmann, M. Scheffner, and F. Hoppe-Seyler, “Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6693–6697, 2000. View at Publisher · View at Google Scholar · View at Scopus
- P. Seth, U. Brinkmann, G. N. Schwartz et al., “Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging,” Cancer Research, vol. 56, no. 6, pp. 1346–1351, 1996. View at Google Scholar · View at Scopus
- S. R. Quist, S. Wang-Gohrke, T. Köhler, R. Kreienberg, and I. B. Runnebaum, “Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status,” Cancer Gene Therapy, vol. 11, no. 8, pp. 547–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. Hietanen, S. Lain, E. Krausz, C. Blattner, and D. P. Lane, “Activation of p53 in cervical carcinoma cells by small molecules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8501–8506, 2000. View at Publisher · View at Google Scholar · View at Scopus
- T. Maehama, A. Patzelt, M. Lengert et al., “Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose,” International Journal of Cancer, vol. 76, no. 5, pp. 639–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
- J. Nemunaitis, S. G. Swisher, T. Timmons et al., “Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 18, no. 3, pp. 609–622, 2000. View at Google Scholar
- C. P. Martins, L. Brown-Swigart, and G. I. Evan, “Modeling the therapeutic efficacy of p53 restoration in tumors,” Cell, vol. 127, no. 7, pp. 1323–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
- A. Ventura, D. G. Kirsch, M. E. McLaughlin et al., “Restoration of p53 function leads to tumour regression in vivo,” Nature, vol. 445, no. 7128, pp. 661–665, 2007. View at Publisher · View at Google Scholar · View at Scopus
- W. Xue, L. Zender, C. Miething et al., “Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas,” Nature, vol. 445, no. 7128, pp. 656–660, 2007. View at Publisher · View at Google Scholar · View at Scopus
- C. H. Wu, J. van Riggelen, A. Yetil et al., “Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 13028–13033, 2007. View at Publisher · View at Google Scholar
- L. Soucek, J. Whitfield, C. P. Martins et al., “Modelling Myc inhibition as a cancer therapy,” Nature, vol. 455, no. 7213, pp. 679–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
- I. B. Roninson, “Tumor senescence as a determinant of drug response in vivo,” Drug Resistance Updates, vol. 5, no. 5, pp. 204–208, 2002. View at Publisher · View at Google Scholar · View at Scopus
- B.-D. Chang, E. V. Broude, M. Dokmanovic et al., “A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents,” Cancer Research, vol. 59, no. 15, pp. 3761–3767, 1999. View at Google Scholar
- B. D. Chang, Y. Xuan, E. V. Broude et al., “Role of p53 and in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs,” Oncogene, vol. 18, no. 34, pp. 4808–4818, 1999. View at Publisher · View at Google Scholar · View at Scopus
- L. W. Elmore, C. W. Rehder, X. Di et al., “Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 35509–35515, 2002. View at Publisher · View at Google Scholar · View at Scopus
- X. Wang, S. C. H. Wong, J. Pan et al., “Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells,” Cancer Research, vol. 58, no. 22, pp. 5019–5022, 1998. View at Google Scholar · View at Scopus
- R. H. te Poele, A. L. Okorokov, L. Jardine, J. Cummings, and S. P. Joel, “DNA damage is able to induce senescence in tumor cells in vitro and in vivo,” Cancer Research, vol. 62, no. 6, pp. 1876–1883, 2002. View at Google Scholar
- M. Collado, M. A. Blasco, and M. Serrano, “Cellular senescence in cancer and aging,” Cell, vol. 130, no. 2, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
- V. Paradis, N. Youssef, D. Dargère et al., “Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas,” Human Pathology, vol. 32, no. 3, pp. 327–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
- J. J. Going, R. C. Stuart, M. Downie, A. J. Fletcher-Monaghan, and W. N. Keith, “‘Senescence-associated’ β-galactosidase activity in the upper gastrointestinal tract,” Journal of Pathology, vol. 196, no. 4, pp. 394–400, 2002. View at Publisher · View at Google Scholar
- S. U. Wiemann, A. Satyanarayana, M. Tsahuridu et al., “Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis,” FASEB Journal, vol. 16, no. 9, pp. 935–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
- U. Herbig, M. Ferreira, L. Condel, D. Carey, and J. M. Sedivy, “Cellular senescence in aging primates,” Science, vol. 311, no. 5765, p. 1257, 2006. View at Publisher · View at Google Scholar · View at Scopus
- K. Mishima, J. T. Handa, A. Aotaki-Keen, G. A. Lutty, L. S. Morse, and L. M. Hjelmeland, “Senescence-associated β-galactosidase histochemistry for the primate eye,” Investigative Ophthalmology and Visual Science, vol. 40, no. 7, pp. 1590–1593, 1999. View at Google Scholar · View at Scopus
- J. C. Jeyapalan, M. Ferreira, J. M. Sedivy, and U. Herbig, “Accumulation of senescent cells in mitotic tissue of aging primates,” Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 36–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. S. Price, J. G. Waters, C. Darrah et al., “The role of chondrocyte senescence in osteoarthritis,” Aging Cell, vol. 1, no. 1, pp. 57–65, 2002. View at Google Scholar · View at Scopus
- M. Fenton, S. Barker, D. J. Kurz, and J. D. Erusalimsky, “Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 2, pp. 220–226, 2001. View at Google Scholar · View at Scopus
- C. Matthews, I. Gorenne, S. Scott et al., “Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress,” Circulation Research, vol. 99, no. 2, pp. 156–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
- E. Vasile, Y. Tomita, L. F. Brown, O. Kocher, and H. F. Dvorak, “Differential expression of thymosin β-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis,” FASEB Journal, vol. 15, no. 2, pp. 458–466, 2001. View at Publisher · View at Google Scholar · View at Scopus
- T. Minamino and I. Komuro, “Vascular cell senescence: contribution to atherosclerosis,” Circulation Research, vol. 100, no. 1, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
- B. E. Flanary, N. W. Sammons, C. Nguyen, D. Walker, and W. J. Streit, “Evidence that aging and amyloid promote microglial cell senescence,” Rejuvenation Research, vol. 10, no. 1, pp. 61–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
- T. Tsuji, K. Aoshiba, and A. Nagai, “Alveolar cell senescence in patients with pulmonary emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 8, pp. 886–893, 2006. View at Publisher · View at Google Scholar · View at Scopus
- K.-C. Müller, L. Welker, K. Paasch et al., “Lung fibroblasts from patients with emphysema showmarkers of senescence in vitro,” Respiratory Research, vol. 7, article 32, 2006. View at Publisher · View at Google Scholar
- E. L. Schneider and Y. Mitsui, “The relationship between in vitro cellular aging and in vivo human age,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 10, pp. 3584–3588, 1976. View at Google Scholar · View at Scopus
- J. G. Rheinwald and H. Green, “Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells,” Cell, vol. 6, no. 3, pp. 331–334, 1975. View at Google Scholar · View at Scopus
- G. M. Martin, C. A. Sprague, and C. J. Epstein, “Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype,” Laboratory Investigation, vol. 23, no. 1, pp. 86–92, 1970. View at Google Scholar · View at Scopus
- S. A. Bruce, S. F. Deamond, and P. O. P. Ts'o, “In vitro senescence of syrian hamster mesenchymal cells of fetal to aged adult origin. Inverse relationship between in vivo donor age and in vitro proliferative capacity,” Mechanisms of Ageing and Development, vol. 34, no. 2, pp. 151–173, 1986. View at Google Scholar · View at Scopus
- E. L. Bierman, “The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells,” In Vitro, vol. 14, no. 11, pp. 951–955, 1978. View at Google Scholar · View at Scopus
- V. J. Cristofalo, R. G. Allen, R. J. Pignolo, B. G. Martin, and J. C. Beck, “Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10614–10619, 1998. View at Publisher · View at Google Scholar · View at Scopus
- S. Goldstein, S. Murano, H. Benes et al., “Studies on the molecular-genetic basis of replicative senescence in Werner syndrome and normal fibroblasts,” Experimental Gerontology, vol. 24, no. 5-6, pp. 461–468, 1989. View at Publisher · View at Google Scholar · View at Scopus
- K. I. Nakamura, N. Izumiyama-Shimomura, M. Sawabe et al., “Comparative analysis of telomere lengths and erosion with age in human epidermis and lingual epithelium,” Journal of Investigative Dermatology, vol. 119, no. 5, pp. 1014–1019, 2002. View at Publisher · View at Google Scholar · View at Scopus
- R. C. Allsopp, H. Vaziri, C. Patterson et al., “Telomere length predicts replicative capacity of human fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10114–10118, 1992. View at Publisher · View at Google Scholar · View at Scopus
- R. M. Cawthon, K. R. Smith, E. O'Brien, A. Sivatchenko, and R. A. Kerber, “Association between telomere length in blood and mortality in people aged 60 years or older,” The Lancet, vol. 361, no. 9355, pp. 393–395, 2003. View at Publisher · View at Google Scholar · View at Scopus
- N. D. Hastie, M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green, and R. C. Allshire, “Telomere reduction in human colorectal carcinoma and with ageing,” Nature, vol. 346, no. 6287, pp. 866–868, 1990. View at Publisher · View at Google Scholar · View at Scopus
- M. Sugimoto, R. Yamashita, and M. Ueda, “Telomere length of the skin in association with chronological aging and photoaging,” Journal of Dermatological Science, vol. 43, no. 1, pp. 43–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
- A. Melk, V. Ramassar, L. M. H. Helms et al., “Telomere shortening in kidneys with age,” Journal of the American Society of Nephrology, vol. 11, no. 3, pp. 444–453, 2000. View at Google Scholar · View at Scopus
- K. Takubo, K. I. Nakamura, N. Izumiyama et al., “Telomere shortening with aging in human liver,” The Journals of Gerontology Series A, vol. 55, no. 11, pp. B533–B536, 2000. View at Google Scholar · View at Scopus
- H. Aikata, H. Takaishi, Y. Kawakami et al., “Telomere reduction in human liver tissues with age and chronic inflammation,” Experimental Cell Research, vol. 256, no. 2, pp. 578–582, 2000. View at Publisher · View at Google Scholar · View at Scopus
- G. M. Baerlocher, I. Vulto, G. de Jong, and P. M. Lansdorp, “Flow cytometry and FISH to measure the average length of telomeres (flow FISH),” Nature Protocols, vol. 1, no. 5, pp. 2365–2376, 2006. View at Publisher · View at Google Scholar · View at Scopus
- A. Canela, E. Vera, P. Klatt, and M. A. Blasco, “High-throughput telomere length quantification by FISH and its application to human population studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 13, pp. 5300–5305, 2007. View at Publisher · View at Google Scholar · View at Scopus
- E. Chang and C. B. Harley, “Telomere length and replicative aging in human vascular tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 11190–11194, 1995. View at Publisher · View at Google Scholar · View at Scopus
- M. Kimura, M. Barbieri, J. P. Gardner et al., “Leukocytes of exceptionally old persons display ultra-short telomeres,” American Journal of Physiology, vol. 293, no. 6, pp. R2210–R2217, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Kveiborg, M. Kassem, B. Langdahl, E. F. Eriksen, B. F. C. Clark, and S. I. S. Rattan, “Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients,” Mechanisms of Ageing and Development, vol. 106, no. 3, pp. 261–271, 1999. View at Publisher · View at Google Scholar · View at Scopus
- C. Mondello, C. Petropoulou, D. Monti, E. S. Gonos, C. Franceschi, and F. Nuzzo, “Telomere length in fibroblasts and blood cells from healthy centenarians,” Experimental Cell Research, vol. 248, no. 1, pp. 234–242, 1999. View at Publisher · View at Google Scholar · View at Scopus
- T. Kitada, S. Seki, N. Kawakita, T. Kuroki, and T. Monna, “Telomere shortening in chronic liver diseases,” Biochemical and Biophysical Research Communications, vol. 211, no. 1, pp. 33–39, 1995. View at Publisher · View at Google Scholar · View at Scopus
- N. Miura, I. Horikawa, A. Nishimoto et al., “Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis,” Cancer Genetics and Cytogenetics, vol. 93, no. 1, pp. 56–62, 1997. View at Publisher · View at Google Scholar · View at Scopus
- Y. Urabe, K. Nouso, T. Higashi et al., “Telomere length in human liver diseases,” Liver, vol. 16, no. 5, pp. 293–297, 1996. View at Google Scholar · View at Scopus
- S. E. Ball, F. M. Gibson, S. Rizzo, J. A. Tooze, J. C. W. Marsh, and E. C. Gordon-Smith, “Progressive telomere shortening in aplastic anemia,” Blood, vol. 91, no. 10, pp. 3582–3592, 1998. View at Google Scholar · View at Scopus
- N. J. Samani, R. Boultby, R. Butler, J. R. Thompson, and A. H. Goodall, “Telomere shortening in atherosclerosis,” The Lancet, vol. 358, no. 9280, pp. 472–473, 2001. View at Publisher · View at Google Scholar · View at Scopus
- N. Obana, S. Takagi, Y. Kinouchi et al., “Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders,” Internal Medicine, vol. 42, no. 2, pp. 150–153, 2003. View at Google Scholar · View at Scopus
- L. A. Panossian, V. R. Porter, H. F. Valenzuela et al., “Telomere shortening in T cells correlates with Alzheimer's disease status,” Neurobiology of Aging, vol. 24, no. 1, pp. 77–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
- M. Ogami, Y. Ikura, M. Ohsawa et al., “Telomere shortening in human coronary artery diseases,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 546–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
- E. S. Epel, E. H. Blackburn, J. Lin et al., “Accelerated telomere shortening in response to life stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17312–17315, 2004. View at Publisher · View at Google Scholar · View at Scopus
- A. M. Valdes, T. Andrew, J. P. Gardner et al., “Obesity, cigarette smoking, and telomere length in women,” The Lancet, vol. 366, no. 9486, pp. 662–664, 2005. View at Publisher · View at Google Scholar · View at Scopus
- T. Vulliamy, A. Marrone, R. Szydlo, A. Walne, P. J. Mason, and I. Dokal, “Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC,” Nature Genetics, vol. 36, no. 5, pp. 447–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
- T. Vulliamy, A. Marrone, F. Goldman et al., “The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita,” Nature, vol. 413, no. 6854, pp. 432–435, 2001. View at Publisher · View at Google Scholar · View at Scopus
- H. Yamaguchi, R. T. Calado, H. Ly et al., “Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia,” The New England Journal of Medicine, vol. 352, no. 14, pp. 1413–1424, 2005. View at Publisher · View at Google Scholar · View at Scopus
- H. W. Lee, M. A. Blasco, G. J. Gottlieb, J. W. Horner, C. W. Greider, and R. A. DePinho, “Essential role of mouse telomerase in highly proliferative organs,” Nature, vol. 392, no. 6676, pp. 569–574, 1998. View at Publisher · View at Google Scholar · View at Scopus
- L. Y. Hao, M. Armanios, M. A. Strong et al., “Short telomeres, even in the presence of telomerase, limit tissue renewal capacity,” Cell, vol. 123, no. 6, pp. 1121–1131, 2005. View at Publisher · View at Google Scholar · View at Scopus
- M. Jaskelioff, F. L. Muller, J.-H. Paik et al., “Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice,” Nature, vol. 469, no. 7328, pp. 102–107, 2011. View at Publisher · View at Google Scholar
- S. Chang, A. S. Multani, N. G. Cabrera et al., “Essential role of limiting telomeres in the pathogenesis of Werner syndrome,” Nature Genetics, vol. 36, no. 8, pp. 877–882, 2004. View at Publisher · View at Google Scholar · View at Scopus
- X. Du, J. Shen, N. Kugan et al., “Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes,” Molecular and Cellular Biology, vol. 24, no. 19, pp. 8437–8446, 2004. View at Publisher · View at Google Scholar · View at Scopus
- D. J. Rossi, C. H. M. Jamieson, and I. L. Weissman, “Stems cells and the pathways to aging and cancer,” Cell, vol. 132, no. 4, pp. 681–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
- T. A. Rando, “Stem cells, ageing and the quest for immortality,” Nature, vol. 441, no. 7097, pp. 1080–1086, 2006. View at Publisher · View at Google Scholar · View at Scopus
- I. Beerman, W. J. Maloney, I. L. Weissmann, and D. J. Rossi, “Stem cells and the aging hematopoietic system,” Current Opinion in Immunology, vol. 22, no. 4, pp. 500–506, 2010. View at Publisher · View at Google Scholar
- S. Zimmermann, M. Voss, S. Kaiser, U. Kapp, C. F. Waller, and U. M. Martens, “Lack of telomerase activity in human mesenchymal stem cells,” Leukemia, vol. 17, no. 6, pp. 1146–1149, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. J. Morrison, K. R. Prowse, P. Ho, and I. L. Weissman, “Telomerase activity in hematopoietic cells is associated with self-renewal potential,” Immunity, vol. 5, no. 3, pp. 207–216, 1996. View at Publisher · View at Google Scholar · View at Scopus
- R. C. Allsopp, G. B. Morin, R. DePinho, C. B. Harley, and I. L. Weissman, “Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation,” Blood, vol. 102, no. 2, pp. 517–520, 2003. View at Publisher · View at Google Scholar · View at Scopus
- J. Yui, C. P. Chiu, and P. M. Lansdorp, “Telomerase activity in candidate stem cells from fetal liver and adult bone marrow,” Blood, vol. 91, no. 9, pp. 3255–3262, 1998. View at Google Scholar · View at Scopus
- R. C. Allsopp, S. Cheshier, and I. L. Weissman, “Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells,” Journal of Experimental Medicine, vol. 193, no. 8, pp. 917–924, 2001. View at Publisher · View at Google Scholar · View at Scopus
- R. C. Allsopp and I. L. Weissman, “Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role?” Oncogene, vol. 21, no. 21, pp. 3270–3273, 2002. View at Publisher · View at Google Scholar · View at Scopus
- H. Vaziri, W. Dragowska, R. C. Allsopp, T. E. Thomas, C. B. Harley, and P. M. Lansdorp, “Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9857–9860, 1994. View at Publisher · View at Google Scholar · View at Scopus
- J. Krishnamurthy, C. Torrice, M. R. Ramsey et al., “Ink4a/Arf expression is a biomarker of aging,” Journal of Clinical Investigation, vol. 114, no. 9, pp. 1299–1307, 2004. View at Publisher · View at Google Scholar · View at Scopus
- A. B. Chkhotua, E. Gabusi, A. Altimari et al., “Increased expression of p16 and p27 cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy,” American Journal of Kidney Diseases, vol. 41, no. 6, pp. 1303–1313, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. Ressler, J. Bartkova, H. Niederegger et al., “ is a robust in vivo biomarker of cellular aging in human skin,” Aging Cell, vol. 5, no. 5, pp. 379–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
- G. P. Nielsen, A. O. Stemmer-Rachamimov, J. Shaw, J. E. Roy, J. Koh, and D. N. Louis, “Immunohistochemical survey of expression in normal human adult and infant tissues,” Laboratory Investigation, vol. 79, no. 9, pp. 1137–1143, 1999. View at Google Scholar · View at Scopus
- A. Melk, B. M. W. Schmidt, O. Takeuchi, B. Sawitzki, D. C. Rayner, and P. F. Halloran, “Expression of and other cell cycle regulator and senescence associated genes in aging human kidney,” Kidney International, vol. 65, no. 2, pp. 510–520, 2004. View at Publisher · View at Google Scholar
- H. Chen, X. Gu, I. H. Su et al., “Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus,” Genes & Development, vol. 23, no. 8, pp. 975–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
- F. Zindy, D. E. Quelle, M. F. Roussel, and C. J. Sherr, “Expression of the tumor suppressor versus other INK4 family members during mouse development and aging,” Oncogene, vol. 15, no. 2, pp. 203–211, 1997. View at Google Scholar · View at Scopus
- J. Krishnamurthy, M. R. Ramsey, K. L. Ligon et al., “ induces an age-dependent decline in islet regenerative potential,” Nature, vol. 443, no. 7110, pp. 453–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
- V. Janzen, R. Forkert, H. E. Fleming et al., “Stem-cell ageing modified by the cyclin-dependent kinase inhibitor ,” Nature, vol. 443, no. 7110, pp. 421–426, 2006. View at Publisher · View at Google Scholar · View at Scopus
- A. V. Molofsky, S. G. Slutsky, N. M. Joseph et al., “Increasing expression decreases forebrain progenitors and neurogenesis during ageing,” Nature, vol. 443, no. 7110, pp. 448–452, 2006. View at Publisher · View at Google Scholar · View at Scopus
- T. Cheng, N. Rodrigues, H. Shen et al., “Hematopoietic stem cell quiescence maintained by ,” Science, vol. 287, no. 5459, pp. 1804–1809, 2000. View at Publisher · View at Google Scholar · View at Scopus
- A. R. Choudhury, Z. Ju, M. W. Djojosubroto et al., “Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation,” Nature Genetics, vol. 39, no. 1, pp. 99–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
- Y. Liu, S. E. Elf, Y. Miyata et al., “p53 regulates hematopoietic stem cell quiescence,” Cell Stem Cell, vol. 4, no. 1, pp. 37–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
- M. TeKippe, D. E. Harrison, and J. Chen, “Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice,” Experimental Hematology, vol. 31, no. 6, pp. 521–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
- K. Meletis, V. Wirta, S. M. Hede, M. Nistér, J. Lundeberg, and J. Frisén, “p53 suppresses the self-renewal of adult neural stem cells,” Development, vol. 133, no. 2, pp. 363–369, 2006. View at Publisher · View at Google Scholar · View at Scopus
- S. D. Tyner, S. Venkatachalam, J. Choi et al., “p53 mutant mice that display early ageing-associated phenotypes,” Nature, vol. 415, no. 6867, pp. 45–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
- B. Maier, W. Gluba, B. Bernier et al., “Modulation of mammalian life span by the short isoform of p53,” Genes & Development, vol. 18, no. 3, pp. 306–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. M. Chambers, C. A. Shaw, C. Gatza, C. J. Fisk, L. A. Donehower, and M. A. Goodell, “Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation,” PLoS Biology, vol. 5, no. 8, article e201, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Dumble, L. Moore, S. M. Chambers et al., “The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging,” Blood, vol. 109, no. 4, pp. 1736–1742, 2007. View at Publisher · View at Google Scholar · View at Scopus
- A. Matheu, A. Maraver, P. Klatt et al., “Delayed ageing through damage protection by the Arf/p53 pathway,” Nature, vol. 448, no. 7151, pp. 375–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
- I. García-Cao, M. García-Cao, J. Martín-Caballero et al., “‘Super p53’ mice exhibit enhanced DNA damage response, are tumor resistant and age normally,” The EMBO Journal, vol. 21, no. 22, pp. 6225–6235, 2002. View at Publisher · View at Google Scholar · View at Scopus
- I. García-Cao, M. García-Cao, A. Tomás-Loba et al., “Increased p53 activity does not accelerate telomere-driven ageing,” EMBO Reports, vol. 7, no. 5, pp. 546–552, 2006. View at Publisher · View at Google Scholar · View at Scopus